The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the Poliwogg Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.
Healthcare stocks and top healthcare ETFs rallied Friday after President Donald Trump vowed to end to “global freeloading” that has allowed foreign countries to pay less on American-manufactured medicines. The…
Biotechnology stocks bolstered the broader healthcare sector last year, a theme that is expected to continue in 2018. Investors looking for a way to access potentially smaller biotechnology companies can…
The biotechnology segment rallied Monday with small-cap biotech names and related exchange traded funds leading the charge after Gilead Sciences (NasdaqGS: GILD) acquired Kite Pharma (NasdaqGS: KITE). The iShares Nasdaq…
U.S. equities and stock exchange traded funds ended February on a sullen note, with the Dow Jones Industrial Average snapping a 12-day winning streak, as cautious investors await President Donald…
Healthcare stocks, especially the biotech segment, and related exchange traded funds plunged Wednesday after President-elect Donald Trump singled out the rising drug prices at a press conference. The healthcare sector…
Biotechnology stocks and sector-related exchange traded funds surged Wednesday as Vice President-elect Mike Pence stated that President-elect Donald Trump’s “first order of business” was to repeal the Affordable Care Act…
$38.98 
